Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citigroup Maintains Buy on Passage Bio, Lowers Price Target to $5

Citigroup analyst Neena Bitritto-Garg maintains Passage Bio (NASDAQ:PASG) with a Buy and lowers the price target from $7 to $5.
byBenzinga Newsdesk
November 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Citigroup analyst Neena Bitritto-Garg maintains Passage Bio (NASDAQ:PASG) with a Buy and lowers the price target from $7 to $5.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts